OssDsign AB (SE:OSSD)
:OSSD
Want to see SE:OSSD full AI Analyst Report?
OSSD Stock Chart & Stats
kr11.30
-kr0.12(-0.97%)
At close: 4:00 PM EST
kr11.30
-kr0.12(-0.97%)
Day’s Range― - ―
52-Week Rangekr3.34 - kr16.72
Previous CloseN/A
Volume95.81K
Average Volume (3M)297.02K
Market Cap
kr453.01M
Enterprise Valuekr269.12M
Total Cash (Recent Filing)kr191.35M
Total Debt (Recent Filing)kr1.37M
Price to Earnings (P/E)―
Beta-0.46
Next Earnings
May 20, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding110,625,916
10 Day Avg. Volume325,245
30 Day Avg. Volume297,022
Financial Highlights & Ratios
PEG Ratio3.07
Price to Book (P/B)4.04
Price to Sales (P/S)6.95
P/FCF Ratio-17.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.33
Revenue Forecast (FY)kr213.15M
Bulls Say, Bears Say
Bulls Say
Revenue AccelerationMaterial revenue acceleration indicates strong product-market fit and expanding adoption of OssDsign’s implant solutions. Sustained top-line growth over several quarters supports scaling advantages, improves bargaining power with providers and distributors, and creates a clearer path to cover fixed costs long-term.
Exceptional Gross MarginsVery high and improving gross margins point to attractive unit economics from proprietary materials and implant design. These margins provide structural leverage: if operating spend growth moderates, high product-level profitability can translate into sustainable operating profits and cash generation.
Low Financial LeverageA conservatively financed balance sheet with minimal debt reduces bankruptcy and interest-rate risks, giving management flexibility to invest organically or fund growth through equity. Low leverage lengthens runway while the company works to convert growth and margins into positive cash flow.
Bears Say
Negative Operating & Free Cash FlowPersistent large cash burn forces reliance on external capital and creates dilution or financing risk. Until operating cash flow turns positive, the company’s growth must be financed externally, which constrains strategic optionality and makes long-term viability dependent on sustained revenue improvement or new funding.
Ongoing Operating LossesDespite strong revenue and gross margins, negative EBIT and net margins show fixed and operating costs outpace product economics. Structural profitability requires either continued rapid revenue scaling with controlled SG&A or meaningful cost reductions, both of which are uncertain over the medium term.
Negative Return On EquityA negative ROE indicates capital deployed has not generated shareholder returns and that accumulated losses have pressured profitability metrics. If losses persist, the equity base may be eroded or require additional injections, increasing dilution risk and lowering long-term investor return prospects.
OssDsign AB News
OSSD FAQ
What was OssDsign AB’s price range in the past 12 months?
OssDsign AB lowest stock price was kr3.33 and its highest was kr16.72 in the past 12 months.
What is OssDsign AB’s market cap?
OssDsign AB’s market cap is kr453.01M.
When is OssDsign AB’s upcoming earnings report date?
OssDsign AB’s upcoming earnings report date is May 20, 2026 which is in 19 days.
How were OssDsign AB’s earnings last quarter?
OssDsign AB released its earnings results on Feb 03, 2026. The company reported -kr0.2 earnings per share for the quarter, missing the consensus estimate of -kr0.17 by -kr0.03.
Is OssDsign AB overvalued?
According to Wall Street analysts OssDsign AB’s price is currently Overvalued.
Does OssDsign AB pay dividends?
OssDsign AB does not currently pay dividends.
What is OssDsign AB’s EPS estimate?
OssDsign AB’s EPS estimate is -0.08.
How many shares outstanding does OssDsign AB have?
OssDsign AB has 110,625,916 shares outstanding.
What happened to OssDsign AB’s price movement after its last earnings report?
OssDsign AB reported an EPS of -kr0.2 in its last earnings report, missing expectations of -kr0.17. Following the earnings report the stock price went down -25.258%.
Which hedge fund is a major shareholder of OssDsign AB?
Currently, no hedge funds are holding shares in SE:OSSD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OssDsign AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Technical Analysis
Paxman AB
―
Senzime AB
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Sedana Medical AB
―